Acadia Pharmaceuticals ACAD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.64M-80.8% | $273.57M+90.3% | $71.78M+119% | $26.67M-20.1% | $18.99M+14.7% | ||
| $271K+18.3% | $202K-10.6% | $227K+0.4% | $213K-5.8% | $229K-5.4% | ||
| $14.7M+29.2% | $13.24M+26.7% | $13.18M-49.6% | $14.34M-8.6% | $11.38M-22.8% | ||
| $33.98M+67.2% | —— | $74.29M+17.5% | $63.96M+156% | $20.32M-30.1% | ||
| $5.21M— | $4.01M+784% | $388K+454% | $297K— | $0— | ||
| $66.28M+153% | -$55.87M— | -$79.35M+3.8% | -$43.29M+23.0% | -$124.05M-784% | ||
| $4.23M+130% | $22.67M+1,051% | $9.42M+3,416% | $15.96M+348% | $1.84M+76.2% | ||
| $104.52M+203% | -$81.93M-150% | —— | —— | -$101.89M-733% | ||
| $28.77M+41.6% | —— | $73.9M+17.0% | $63.66M— | $20.32M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Acadia Pharmaceuticals generate?
- Acadia Pharmaceuticals (ACAD) generated $192.5M in operating cash flow over the trailing twelve months.
- What is Acadia Pharmaceuticals's free cash flow?
- After $9.9M of capital expenditures, Acadia Pharmaceuticals's free cash flow was $186.7M over the trailing twelve months, up 13.4% year over year.
- Where does Acadia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
